Health Care & Life Sciences » Pharmaceuticals | Purapharm Corp. Ltd.

Purapharm Corp. Ltd.

Purapharm Corp. Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.08
Market Cap
HKD514.97 M
Shares Outstanding
247.72 M
Public Float
99.51 M

Profile

Address
Suite 4002, Jardine House
Hong Kong
Hong Kong
Employees -
Website http://www.purapharm.com
Updated 07/08/2019
PuraPharm Corp. Ltd. operates as an investment holding company. It engages in the research and development, production and sale of concentrated Chinese medicine granule (CCMG) products and Chinese healthcare products, as well as rendering of Chinese medical diagnostic services. The company operates through the following segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, and Clinics.

Financials

View All

Stanley Chow
Non-Executive Director
Kin Man Chan
Executive Director